Mirae Asset Global Investments Portfolio holdings
AUM
$28.7B
1-Year Return
20.96%
This Quarter Return
+7.12%
1 Year Return
+20.96%
3 Year Return
+114.88%
5 Year Return
+202.83%
10 Year Return
+496.23%
AUM
$20.1B
AUM Growth
-$26B
(-56%)
Cap. Flow
-$35.8B
Cap. Flow
% of AUM
-178.2%
Top 10 Holdings %
Top 10 Hldgs %
37.49%
Holding
2,693
New
259
Increased
178
Reduced
1,071
Closed
1,170
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$78.3M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$69.3M |
| 3 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$67.8M |
| 4 |
SPDR Portfolio Long Term Treasury ETF
SPTL
|
+$51.6M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$49.3M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$3.09B |
| 2 |
Microsoft
MSFT
|
+$2.03B |
| 3 |
Apple
AAPL
|
+$1.62B |
| 4 |
Amazon
AMZN
|
+$1.15B |
| 5 |
Meta Platforms (Facebook)
META
|
+$886M |
Sector Composition
| 1 | Technology | 34.49% |
| 2 | Consumer Discretionary | 8.59% |
| 3 | Communication Services | 8.54% |
| 4 | Healthcare | 6.84% |
| 5 | Financials | 4.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1426
ACI Worldwide
ACIW
$5.18B
| $15K | ﹤0.01% |
378
-201,069
| -100% | -$7.96M |
|
|
UHT
1427
Universal Health Realty Income Trust
UHT
$575M
| $14.6K | ﹤0.01% |
+378
| New | +$14.6K |
|
|
ALX
1428
Alexander's
ALX
$1.25B
| $14.6K | ﹤0.01% |
66
-60,888
| -100% | -$13.5M |
|
1429
Shift4
FOUR
$6B
| $14.5K | ﹤0.01% |
198
-71,541
| -100% | -$5.25M |
|
|
DHC
1430
Diversified Healthcare Trust
DHC
$1.07B
| $14.4K | ﹤0.01% |
4,847
-71,037
| -94% | -$211K |
|
1431
Oric Pharmaceuticals
ORIC
$1.05B
| $13.9K | ﹤0.01% |
+2,013
| New | +$13.9K |
|
1432
Terns Pharmaceuticals
TERN
$633M
| $13.7K | ﹤0.01% |
+1,931
| New | +$13.7K |
|
1433
Teladoc Health
TDOC
$1.36B
| $13.7K | ﹤0.01% |
1,347
-208,342
| -99% | -$2.11M |
|
|
BFS
1434
Saul Centers
BFS
$785M
| $13.6K | ﹤0.01% |
+380
| New | +$13.6K |
|
1435
EyePoint Pharmaceuticals
EYPT
$920M
| $13.6K | ﹤0.01% |
+1,555
| New | +$13.6K |
|
|
LAND
1436
Gladstone Land Corp
LAND
$321M
| $13.3K | ﹤0.01% |
981
-13,600
| -93% | -$184K |
|
1437
OmniAb
OABI
$236M
| $13.2K | ﹤0.01% |
+3,511
| New | +$13.2K |
|
1438
Alector
ALEC
$278M
| $13.1K | ﹤0.01% |
2,878
-49,765
| -95% | -$226K |
|
1439
Voyager Therapeutics
VYGR
$232M
| $12.8K | ﹤0.01% |
+1,624
| New | +$12.8K |
|
1440
MaxCyte
MXCT
$155M
| $12.5K | ﹤0.01% |
3,121
-39,351
| -93% | -$157K |
|
1441
nCino
NCNO
$3.48B
| $12.4K | ﹤0.01% |
393
-149,781
| -100% | -$4.71M |
|
1442
Theravance Biopharma
TBPH
$720M
| $12.1K | ﹤0.01% |
1,452
-51,424
| -97% | -$428K |
|
1443
Taysha Gene Therapies
TSHA
$837M
| $12.1K | ﹤0.01% |
+5,583
| New | +$12.1K |
|
|
VERV
1444
DELISTED
Verve Therapeutics
VERV
| $11.9K | ﹤0.01% |
2,507
-169,288
| -99% | -$806K |
|
|
ENV
1445
DELISTED
ENVESTNET, INC.
ENV
| $11.8K | ﹤0.01% |
188
-105,350
| -100% | -$6.59M |
|
1446
AC Immune
ACIU
$244M
| $11.7K | ﹤0.01% |
+2,953
| New | +$11.7K |
|
1447
StoneCo
STNE
$4.89B
| $11.7K | ﹤0.01% |
977
-540,967
| -100% | -$6.49M |
|
|
SLRN
1448
DELISTED
ACELYRIN
SLRN
| $11.7K | ﹤0.01% |
+2,956
| New | +$11.7K |
|
1449
Fulcrum Therapeutics
FULC
$379M
| $11.7K | ﹤0.01% |
1,856
-30,735
| -94% | -$193K |
|
1450
Editas Medicine
EDIT
$242M
| $11.6K | ﹤0.01% |
2,455
-312,319
| -99% | -$1.48M |
|